Aegle Therapeutics is excited to present at #BiotechShowcase on January 8th! We hope to see you in San Francisco for the healthcare conference.
Aegle Therapeutics’ Post
More Relevant Posts
-
In this K-Cast episode, Diana Brixner, discusses the level of clinical evidence payers should expect and require from non-prescription digital health tools compared to FDA-approved digital therapeutics! Brixner offers insight as to where the biggest gaps in evidence generation for digital therapeutics come from. Watch here: https://bit.ly/4drOvLE #ManagedCare #DigitalHealth
To view or add a comment, sign in
-
In a recent CRA webinar on evolving business models for DTx (Digital Therapeutics) Rhett Johnson and Andy Parece discussed with a panel of industry leaders, Richard DeNunzio, Omar Manejwala, M.D., and Brion Raymond, how events in the past year, from introduction of new HSPCS billing codes to Pear Therapeutics’ bankruptcy and the transition of some DTx manufacturers to alternative business models, impact their companies. Each panelist discussed business models their company is employing, including prescription digital therapeutics, collaboration with employers to fund solutions and with pharma companies to collaborate partner in research and commercialization. The discussion covered the drivers behind the choice of each business model as well as their advantages, and showed how they are related to the specific product, indication and available clinical evidence base. To learn more and watch the webinar recording, click here: https://lnkd.in/gjdbCBTd #DigitalTherapeutics
To view or add a comment, sign in
-
Did you know that 72% of healthcare professionals are concerned about the credibility of Digital Therapeutics (DTx)? However, DTx can vastly improve patient outcomes and engagement. Find out how to overcome the challenges in our latest report on digital therapeutics. https://bit.ly/3wYtHKT #DTx #digitalhealthcare #IQVIA
To view or add a comment, sign in
-
Are you interested in learning more about the emerging field of digital therapeutics? Join the upcoming virtual event "Understanding Digital Therapeutics: An Introduction to the DTx Industry" on Tuesday, September 12, 2023 from 10:30am-12:30pm ET. This event provides an overview of digital therapeutics (DTx) and how this new category of evidence-based digital health interventions is transforming healthcare. You'll learn: -Definition of Digital Therapeutics and how they work -The benefits DTx can provide to patients, providers, and payers -How DTx products are clinically validated and regulated -Business models and go-to-market strategies for DTx -The current state of adoption and reimbursement for digital therapeutics With presentations from experts in the field, this is a great opportunity to gain valuable insights into the emerging DTx industry. Seats are limited, so be sure to register now: https://lnkd.in/gTMusydm #DTACommunity #Digitalhealth #Futureofmedicine
Understanding Digital Therapeutics: An Introduction to the DTx Industry
eventbrite.com
To view or add a comment, sign in
-
Wrapping up the 19th Annual HD Therapeutics Conference 2024 with enlightening insights! Here's a brief recap from the final day of the conference. Stay tuned for more updates! #HDResearch #HuntingtonsDisease #ScientificAdvancements #HDAfrica
To view or add a comment, sign in
-
Day 2 of the 2023 Annual National Conference! Below is a panel of speakers who presented on digital therapeutics. Tune in for more coverage today! Pharmacy Benefit Management Institute #PBMI2023 Pharmacy Benefit Management Institute
To view or add a comment, sign in
-
Did you know that DTx has positive benefits for patient outcomes and engagement? Check the latest report below.
Did you know that 72% of healthcare professionals are concerned about the credibility of Digital Therapeutics (DTx)? However, DTx can vastly improve patient outcomes and engagement. Find out how to overcome the challenges in our latest report on digital therapeutics. https://bit.ly/3wYtHKT #DTx #digitalhealthcare #IQVIA
To view or add a comment, sign in
-
Agreed, the patient-centric approach is so important when it comes to treatments.
Making an impact on patients requires persistence and collaboration across many stakeholders. Our lasting alliance with PTC therapeutics and the SMA Foundation is a testimony of what it takes to establish lasting partnerships that truly benefit patients. Until today, the partners meet regularly to discuss remaining needs and what solutions we can bring to patients and their families. Roche’s customer and patient-centric teams are focused on not only bringing innovative treatments but also holistic solutions beyond treatment to patients and societies around the world. Learn more about the unique three-party alliance: http://spkl.io/60464xyGp
Roche | Building a historic alliance to shape the future of SMA
roche.com
To view or add a comment, sign in
889 followers